Target intelligence / Profile preview

Lymphatic capillary

Molecular classification
Other
01

Overview

Lymphatic capillaries are tiny, thin-walled microvessels located in the spaces between cells throughout most tissues of the body (except in the central nervous system and nonvascular tissues)[1][3][5]. Their primary function is to collect excess interstitial fluid—now called lymph once inside these vessels—and return it to the bloodstream, thereby maintaining tissue fluid balance and preventing edema[3][5][7]. Structurally, they consist of overlapping endothelial cells that form flap-like minivalves allowing one-way entry of fluid but preventing backflow[1][2][4]. Anchoring filaments connect these vessels to surrounding tissue; when tissue swells with excess fluid, these filaments pull open the minivalves further to facilitate increased uptake[1][2].\n\nLymphatic capillaries lack smooth muscle and have only a single layer of endothelium on a permeable basement membrane. They do not possess features typical of molecular drug targets such as receptors or enzymes. Instead, they serve as anatomical conduits for immune surveillance and waste removal by transporting lymph through progressively larger vessels toward lymph nodes and eventually back into venous circulation[1][3].\n\nBecause "lymphatic capillary" refers to an anatomical structure rather than a discrete molecule or protein complex (such as an enzyme or receptor), it is not considered a canonical therapeutic target. There are no known drugs that directly interact with or modulate individual lymphatic capillaries.\n\nNote: This entry is marked *is_incorrect = true* because "lymphatic capillary" is not a molecular entity nor recognized therapeutic target class like receptor, enzyme, transporter etc., but rather an anatomical vessel composed primarily of endothelial cells[1][2][4].

Other names
lymph capillaryinitial lymphaticprelymphatic
02

Biological functions

Fluid balance regulationEdema preventionReturn of interstitial fluid to circulation
03

Disease associations

LymphedemaInflammation (secondary involvement)Infection (secondary involvement)
04

Safety considerations

Not a direct therapeutic target; no specific safety concerns as a drug target

Beyond the preview

Go deeper on Lymphatic capillary.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic capillary.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call